Orthofix Medical Inc. Restricted Cash, Current
Orthofix Medical Inc. (OFIX) had Restricted Cash, Current of $595.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashCurrent · last filed 2026-08-05
- 2026-06-30: Restricted Cash, Current $595.00K.
- 2026-03-31: Restricted Cash, Current $592.00K.
- 2025-12-31: Restricted Cash, Current $3.09M.
- 2025-09-30: Restricted Cash, Current $3.09M.
| Period end | Restricted Cash, Current |
|---|---|
| 2026-06-30 | $595.00K 10-Q · filed 2026-08-05 |
| 2026-03-31 | $592.00K 10-Q · filed 2026-05-05 |
| 2025-12-31 | $3.09M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $3.09M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $3.08M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $2.50M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $2.50M 10-K · filed 2026-02-24 |
| 2024-09-30 | $2.50M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $2.50M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $2.50M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $4.65M 10-K · filed 2025-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |